Madrid
Spain
Carlos III Institute of Health - Communicable Diseases Department
Covid-19, SARS-CoV-2, Omicron, vaccines, effectiveness, Pfizer, Moderna
EU, fatal outcome, influenza, hospital, antiviral treatment, risk factors